She is the Protocol Chair for RV329: African Cohort Study; RV262, an international Phase I DNA / MVA HIV vaccine trial; and for RV398,
an upcoming Phase I trial of the VRC01 broadly neutralizing monoclonal antibody administered in acute HIV infection in East Africa and Thailand.